Vaccine-Med @Vaccine-Med: "Dear Investors, Here is your monthly..."

Smart Portfolio

Dear Investors, Here is your monthly update for May 2025 ✨ Despite some volatility, stocks gained in May, driven by tech and AI momentum. Tariff deals and rate shifts boosted sentiment, while crypto hit new highs. Nvidia and Google led AI advances, and economic signals from the Fed, UK, and Middle East kept markets active. 💭 Find out more about what happened in May with eToro's Smart Portfolios Monthly summary here: etoro.turtl.co/story/etoros-investment-office-performance-report-may25 Performance Stats: @Vaccine-Med-> May: -0.54% , QTD: 0.75% YTD: -16.50% Benchmark (SGH - S&P Global 1200 Health Care Sector GICS Level 1 Index) -> May: -4.05% , QTD: -6.16% YTD: -1.45% Best Performer: $CVAC 25.92% Worst Performer: $VIR (Vir Biotechnology Inc) -19.28% Portfolio Indicated Dividend Yield: 1.22% Some of the assets inside the @Vaccine-Med Smart Portfolio are: $MRNA (Moderna Inc) , $PCVX (Vaxcyte Inc) , $BAVA.CO (Bavarian Nordic A/S) , $DVAX , $NVAX (Novavax Inc) , $MRVI (Maravai LifeSciences Holdings Inc.) , $VLA.PA (Valneva SE) , $PSNL (Personalis Inc) ❓ Check out the portfolio fact sheet by clicking the following link: bullaware.com/factsheet/Vaccine-Med This Smart Portfolio is a long-term investment vehicle. Therefore, since market trends can change over time, you should set realistic goals and assess your investment performance over a prolonged period. Please remember past performance is not indicative of any future performance.